PNV - Chart, page-14652

First 14652 Last

Share
Profile

Follow
semiconductor

51 Posts.

13

28/08/22

22:27

Post #: 63371635
Share

Originally posted by steve10: ↑

With SP double topping at $2.18 then falling to form lower lows there was a high probability of SP drop which played out yesterday.

61.8% Fib retrace of the wave indicated $1.71 gap fill price, cup handle 1/3 retrace & 50EMA support were also in the same area.

Most likely shorters took advantage yesterday & caused SP to undershoot. Insto's would also have reduced positions prior to Powell speech. Weak markets in US overnight so there will be more selling for a few days when ASX opens.

Now looking for 200EMA to act as support around $1.55. SP had a good run from 86.5c to 225c intraday peak = x2.6.

$1.55 x 2.6 = $4.03 near prior peak where there should be a lot of resistance. The multiple of the wave tends to repeat on many occasions. There is overhead resistance there too.

If it's going to form a handle now the cup lips are at around 210c - 90c bottom = 120c x 1/3-1/2 = 40-60c.

210c - 40-60c = 170c was near gap fill to 150c is near the 200EMA support. RSI now becoming oversold.

Would have been ideal to retrace to $1.71 gap fill zone but has undershot. Great buying around $1.50 ish levels if it gets there which will enable PNV to pick up more liquidity for the next push higher.

510(k) approval will most likely be catalyst for next push higher along with quarterly update in October.

The numbers were very good in the report. Breaking it down by quarters it works out as follows:

Q1 FY22 - $6.14M
Q2 FY22 - $8.06M
Q3 FY22 - $12.26M
Q4 FY22 - $15.44M x 4 = $61.76M run rate.
TOTAL = $41.9M

H2 FY22 $27.7M / H1 FY22 $14.2M = +95% HOH growth.

Revenue is near doubling every 6 months.

Numbers could have been highlighted better in the report. Needed to highlight the huge HOH growth due to hospitals being open unlike covid lockdowns.

At current HOH growth rate of 95% H1 FY23 revenue will be $54M & H2 FY23 revenue will be $105.3M.

Appears PNV will have circa $150M+ revenue for FY23 based on current growth rate.

This will be bought aggressively once it bottoms as it's now $1,085M MC / $150M FY23e = x7.2 for patented healthcare sector cashflow.

Once the dust settles will double up here around golden cross $1.50ish MA's price if lucky.

Enjoy the weekend.

Expand

Just wanted to flag the numbers you’ve posted. Haven’t had a close look yet but GLOBAL SALES were in AUD:

FY22: 37.6M
H1FY22: 16.272M
Therefore H2FY22 approx 21.328M

So H1FY22 to H2FY22 was ~31% growth, assuming same growth for each half for fy23 gives revenue approx 64.5M.

Looks like you’ve mixed up global/USA sales, and sales/revenue in your 1H numbers. Also HOH means one year. Love the optimism but important to keep it well in check and within reason

PNV Price at posting: $1.64 Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

AW1

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

There are more pages in this discussion • 4,457 more messages in this thread...

First 14652 Last

Add PNV (ASX) to my watchlist

(20min delay)
Last $2.33		Change -0.020(0.85%)		Mkt cap ! $1.608B

Open	High	Low	Value	Volume
$2.32	$2.34	$2.29	$1.770M	763.3K

Buyers (Bids)

No.	Vol.	Price($)
2	5901	$2.33

Sellers (Offers)

Price($)	Vol.	No.
$2.34	6302	2

View Market Depth

No.	Vol.	Price($)
1	3361	2.330
5	11320	2.320
2	8436	2.310
7	44931	2.300
7	8112	2.290

Price($)	Vol.	No.
2.350	36820	7
2.360	8436	2
2.370	4427	2
2.380	2207	1
2.390	2207	1

Last trade - 16.10pm 10/07/2024 (20 minute delay)

PNV (ASX) Chart

PNV - Chart, page-14652

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PNV - Chart, page-14652

Top Stories

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

American West does it again at Storm with visually identified thick copper hits at Cyclone, Lightning Ridge

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News